비교리스트

 카트 문의
시장보고서
상품코드
1588450

부비동 조직 절제술 시장 규모, 점유율 및 동향 분석 보고서 : 제품별, 최종 용도별, 지역별, 부문별 예측(2025-2030년)

Sinus Tissue Resection Market Size, Share & Trends Analysis Report By Product (Endoscopes, Ethmoid Forceps, Nasal Scissors, Curettes), By End-use (Hospitals, Clinics), By Region, And Segment Forecasts, 2025 - 2030
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 140 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

부비동 조직 절제술 시장의 성장과 동향

Grand View Research, Inc.의 최신 보고서에 따르면 부비동 조직 절제술 세계 시장 규모는 2030년까지 3억 1,140만 달러에 달할 것으로 예상되며, 2025-2030년간 5.08%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예상됩니다.

천식, 비염, 알레르기와 같은 만성 질환의 유병률 증가와 주요 시장 진출기업들 간의 경쟁이 시장 성장의 주요 요인으로 작용하고 있으며, Integra LifeSciences와 Medtronic plc와 같은 산업 기업들은 산업 내 입지를 강화하고 부비동 수술 및 이비인후과 수술 부비동 수술 및 이비인후과 수술 제품 포트폴리오를 강화하기 위해 다른 회사를 인수하고 있습니다.

비염과 천식과 같은 만성 질환 증가는 예측 기간 동안 부비동 조직 절제술 시장의 성장을 가속할 것으로 예상되며, WHO가 2023년 5월에 발표한 기사에 따르면 2019년 전 세계적으로 약 45만 5,000명이 천식으로 인해 사망했습니다. 또한 천식은 2 억 6,200 만 명에게 영향을 미쳤습니다. 또한 부비동염은 중증 천식 환자와 관련이 있습니다. 따라서 천식이 있으면 부비동염에 걸릴 확률이 높습니다. 따라서 천식 유병률 증가는 향후 몇 년동안 부비동 조직 절제술 시장의 성장을 가속할 것으로 예상됩니다.

또한, 기술 발전과 제품 출시 증가는 향후 몇 년동안 시장 성장을 가속할 것으로 예상됩니다. 제조업체와 연구자들은 부비동 수술에 도움이 되는 첨단 제품을 개발하고 있습니다. 예를 들어, Springer Nature Limited가 2022년 2월에 발표한 연구에 따르면, 상악동 수술을 위해 조종 가능하고 기능적인 한 손 내시경 PliENT가 개발되었습니다. 이 연구에서는 내시경의 성능을 검사했습니다. 이 내시경을 사용하면 현재 사용되는 내시경에 비해 더 넓은 시야를 얻을 수 있습니다. 이처럼 부비동 및 이비인후과(ENT) 수술을 위한 새로운 내시경의 개발은 시장 성장을 가속할 것으로 기대됩니다.

부비동 조직절제술 시장 보고서 하이라이트

  • 내시경 하위 부문이 제품 부문을 지배하고 2024년매출 점유율은 35.9%를 차지할 것입니다.
  • 비강 가위 제품 부문은 Integra LifeSciences Corporation, Surtex Instruments, Millennium Surgical 등 여러 산업체에서 비강 가위를 제공함에 따라 2025-2030년 가장 빠른 성장률을 보일 것으로 예상됩니다. 가장 빠른 CAGR로 성장할 것으로 예상됩니다.
  • 최종 용도별로는 병원 부문이 2024년 41.80%의 매출 점유율로 시장을 장악했습니다.
  • 클리닉 최종 용도 부문은 클리닉 시설과 관련된 저렴한 비용과 같은 장점으로 인해 향후 몇 년동안 가장 빠른 CAGR을 나타낼 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 세계의 부비동 조직 절제 시장 변수, 동향, 범위

  • 시장 계통 전망
    • 상위 시장 전망
    • 관련/부수 시장 전망
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
  • 세계의 부비동 조직 절제 시장 분석 툴
    • 산업 분석 - Porter의 Five Forces 분석
    • PESTEL 분석

제4장 세계의 부비동 조직 절제 시장 : 제품별, 추정·동향 분석

  • 부문 대시보드
  • 세계의 부비동 조직 절제 시장 : 제품 변동 분석
  • 제품별 세계의 부비동 조직 절제 시장 전망
  • 2018-2030년 시장 규모와 예측과 동향 분석
    • 내시경
    • Ethmoid Forceps
    • Nasal Scissors
    • Curettes
    • 기타

제5장 세계의 부비동 조직 절제 시장 : 최종 용도별, 추정·동향 분석

  • 부문 대시보드
  • 세계의 부비동 조직 절제 시장 : 최종 용도 변동 분석
  • 최종 용도별 세계의 부비동 조직 절제 시장 전망
  • 2018-2030년 시장 규모와 예측과 동향 분석
    • 병원
    • 외래수술센터(ASC)
    • 클리닉
    • 기타

제6장 세계의 부비동 조직 절제 시장 : 지역별, 추정·동향 분석

  • 지역 대시보드
  • 지역별 세계의 부비동 조직 절제 시장 변동 분석
  • 세계의 부비동 조직 절제 시장 : 지역 변동 분석
  • 2018-2030년 시장 규모와 예측과 동향 분석
  • 북미
    • 미국
    • 캐나다
    • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 덴마크
    • 스웨덴
    • 노르웨이
  • 아시아태평양
    • 일본
    • 중국
    • 인도
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
    • 멕시코
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제7장 경쟁 구도

  • 시장 진출기업 분류
  • 주요 기업 개요
    • Medtronic
    • Stryker(Entellus Medical, Inc.)
    • INTEGRA LIFESCIENCES
    • B. Braun Melsungen AG
    • Stille
    • KARL STORZ
    • CARDIMED INTERNATIONAL
    • Novo Surgical Inc
    • Surtex Instruments
    • Xelpov Surgical
LSH 24.11.27

Sinus Tissue Resection Market Growth & Trends:

The global sinus tissue resection market size is expected to reach USD 311.4 million by 2030, registering to grow at a CAGR of 5.08% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing incidence of chronic diseases such as asthma, rhinitis, and allergies and the rising competition among key industry participants are the major factors contributing to the market growth. Companies operating in the industry, such as Integra LifeSciences and Medtronic plc, are acquiring other companies to strengthen their presence in the industry and boost the product portfolio for sinus and ENT surgeries.

The growing incidences of chronic disorders such as rhinitis and Asthma are expected to boost the sinus tissue resection market growth over the forecast period. According to an article published by the WHO in May 2023, approximately 455,000 individuals worldwide died due to Asthma in 2019. In addition, Asthma affected 262 million individuals. Moreover, sinusitis is associated with severe asthma patients. So, having Asthma increases the chances of acquiring a sinus infection. Thus, the rising incidences of Asthma are anticipated to boost the sinus tissue resection market growth in the coming years.

Furthermore, the rising technological advancements and product launches are expected to propel market growth in the coming years. Manufacturers and researchers are developing advanced products to help during sinus surgeries. For instance, according to the study published by Springer Nature Limited in February 2022, a steerable, functional, single-handed endoscope, PliENT, has been developed for maxillary sinus surgery. The performance of the endoscope was inspected in this study. Using this endoscope, an increased field of view can be obtained compared to currently utilized endoscopes. Thus, such novel endoscope developments for sinus and ear nose and throat (ENT) procedures are expected to boost market growth.

Sinus Tissue Resection Market Report Highlights:

  • The endoscope sub-segment dominated the product segment, with a revenue share of 35.9% in 2024, owing to the increasing adoption of minimally invasive procedures.
  • The nasal scissors product segment is expected to grow at the fastest CAGR from 2025 to 2030, due to the availability of nasal scissors from several industry players, such as Integra LifeSciences Corporation, Surtex Instruments, and Millennium Surgical.
  • Based on end-use, the hospital segment dominated the market with a revenue share of 41.80% in 2024, due to the presence of a large number of hospitals conducting various ear nose and throat procedures.
  • The clinics end-use segment is expected to register the fastest CAGR in the coming years, owing to advantages such as lower costs associated with clinic facilities.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. End Use
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Global Sinus Tissue Resection Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing preference for minimally invasive surgeries
      • 3.2.1.2. Advancements in technology
      • 3.2.1.3. Growing prevalence of chronic sinusitis
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Shortage of skilled professionals
      • 3.2.2.2. Limited healthcare spending and lack of awareness in emerging economies
  • 3.3. Global Sinus Tissue Resection Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Global Sinus Tissue Resection Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global Sinus Tissue Resection Market: Product Movement Analysis
  • 4.3. Global Sinus Tissue Resection Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Endoscopes
      • 4.4.1.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Million)
    • 4.4.2. Ethmoid Forceps
      • 4.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 4.4.3. Nasal Scissors
      • 4.4.3.1. Market estimates and forecast 2018 - 2030 (Revenue in USD Million)
    • 4.4.4. Curettes
      • 4.4.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 4.4.5. Others
      • 4.4.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)

Chapter 5. Global Sinus Tissue Resection Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global Sinus Tissue Resection Market: End Use Movement Analysis
  • 5.3. Global Sinus Tissue Resection Market by End Use Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Hospitals
      • 5.4.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 5.4.2. Ambulatory Surgical Centers
      • 5.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 5.4.3. Clinics
      • 5.4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)

Chapter 6. Global Sinus Tissue Resection Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Regional Chapter Global Sinus Tissue Resection Market Movement Analysis
  • 6.3. Global Sinus Tissue Resection Market: Regional Estimates & Trend Analysis
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
  • 6.5. North America
    • 6.5.1. North America Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. U.S.
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Competitive Scenario
      • 6.5.2.3. Regulatory Framework
      • 6.5.2.4. Reimbursement scenario
      • 6.5.2.5. U.S. Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Canada
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Competitive Scenario
      • 6.5.3.3. Regulatory Framework
      • 6.5.3.4. Reimbursement scenario
      • 6.5.3.5. Canada Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
      • 6.5.3.6.
    • 6.5.4. Europe
    • 6.5.5. Europe Global Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. UK
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Competitive Scenario
      • 6.5.6.3. Regulatory Framework
      • 6.5.6.4. Reimbursement scenario
      • 6.5.6.5. UK Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Germany
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Competitive Scenario
      • 6.5.7.3. Regulatory Framework
      • 6.5.7.4. Reimbursement scenario
      • 6.5.7.5. Germany Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. France
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Competitive Scenario
      • 6.5.8.3. Regulatory Framework
      • 6.5.8.4. Reimbursement scenario
      • 6.5.8.5. France Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Italy
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Competitive Scenario
      • 6.5.9.3. Regulatory Framework
      • 6.5.9.4. Reimbursement scenario
      • 6.5.9.5. Italy Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.10. Spain
      • 6.5.10.1. Key Country Dynamics
      • 6.5.10.2. Competitive Scenario
      • 6.5.10.3. Regulatory Framework
      • 6.5.10.4. Reimbursement scenario
      • 6.5.10.5. Spain Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.11. Denmark
      • 6.5.11.1. Key Country Dynamics
      • 6.5.11.2. Competitive Scenario
      • 6.5.11.3. Regulatory Framework
      • 6.5.11.4. Reimbursement scenario
      • 6.5.11.5. Denmark Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.12. Sweden
      • 6.5.12.1. Key Country Dynamics
      • 6.5.12.2. Competitive Scenario
      • 6.5.12.3. Regulatory Framework
      • 6.5.12.4. Reimbursement scenario
      • 6.5.12.5. Sweden Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.13. Norway
      • 6.5.13.1. Key Country Dynamics
      • 6.5.13.2. Competitive Scenario
      • 6.5.13.3. Regulatory Framework
      • 6.5.13.4. Reimbursement scenario
      • 6.5.13.5. Norway Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Competitive Scenario
      • 6.6.2.3. Regulatory Framework
      • 6.6.2.4. Reimbursement scenario
      • 6.6.2.5. Japan Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Competitive Scenario
      • 6.6.3.3. Regulatory Framework
      • 6.6.3.4. Reimbursement scenario
      • 6.6.3.5. China Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Competitive Scenario
      • 6.6.4.3. Regulatory Framework
      • 6.6.4.4. Reimbursement scenario
      • 6.6.4.5. India Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Competitive Scenario
      • 6.6.5.3. Regulatory Framework
      • 6.6.5.4. Reimbursement scenario
      • 6.6.5.5. South Korea Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Competitive Scenario
      • 6.6.6.3. Regulatory Framework
      • 6.6.6.4. Reimbursement scenario
      • 6.6.6.5. Australia Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Competitive Scenario
      • 6.6.7.3. Regulatory Framework
      • 6.6.7.4. Reimbursement scenario
      • 6.6.7.5. Thailand Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Competitive Scenario
      • 6.7.2.3. Regulatory Framework
      • 6.7.2.4. Reimbursement scenario
      • 6.7.2.5. Brazil Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Competitive Scenario
      • 6.7.3.3. Regulatory Framework
      • 6.7.3.4. Reimbursement scenario
      • 6.7.3.5. Argentina Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.7.4. Mexico
      • 6.7.4.1. Key Country Dynamics
      • 6.7.4.2. Competitive Scenario
      • 6.7.4.3. Regulatory Framework
      • 6.7.4.4. Reimbursement scenario
      • 6.7.4.5. Mexico Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.8. Middle East & Africa
    • 6.8.1. Middle East & Africa Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Competitive Scenario
      • 6.8.2.3. Regulatory Framework
      • 6.8.2.4. Reimbursement scenario
      • 6.8.2.5. South Africa Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Competitive Scenario
      • 6.8.3.3. Regulatory Framework
      • 6.8.3.4. Reimbursement scenario
      • 6.8.3.5. Saudi Arabia Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Competitive Scenario
      • 6.8.4.3. Regulatory Framework
      • 6.8.4.4. Reimbursement scenario
      • 6.8.4.5. UAE Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Competitive Scenario
      • 6.8.5.3. Regulatory Framework
      • 6.8.5.4. Reimbursement scenario
      • 6.8.5.5. Kuwait Sinus Tissue Resection Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Key Company Profiles
    • 7.2.1. Medtronic
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Stryker (Entellus Medical, Inc.)
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. INTEGRA LIFESCIENCES
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. B. Braun Melsungen AG
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Stille
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. KARL STORZ
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. CARDIMED INTERNATIONAL
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Novo Surgical Inc
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Surtex Instruments
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives
    • 7.2.10. Xelpov Surgical
      • 7.2.10.1. Company overview
      • 7.2.10.2. Financial performance
      • 7.2.10.3. Product benchmarking
      • 7.2.10.4. Strategic initiatives
비교리스트
0 건의 상품을 선택 중
상품 비교하기
전체삭제